Accenture plc ACN, Salesforce CRM and Mastercard MA have entered into a collaboration, as part of which, Accenture is delivering Salesforce Sustainability Cloud to Mastercard to help it increase its understanding and awareness about emissions of its suppliers.Sustainability Cloud is a platform that helps companies track and assess supplier-level carbon emissions and take suitable climate-related actions.The collaboration builds on Accenture and Salesforce’s ongoing partnership that integrates Accenture’s Sustainability Services, Salesforce Sustainability Cloud, and Salesforce Customer 360, and helps companies attain sustainability in their businesses and contribute to the United Nations Sustainable Development Goals. It is aimed at enabling Mastercard accomplish its Science Based Target to decrease absolute Scope 3 greenhouse gas emissions by 20% by 2025 from a 2016 baseline.Peter Lacy, chief responsibility officer and global sustainability services lead at Accenture, stated, "Leading companies like Mastercard recognize that sustainability is a business imperative that must be embedded across its business to drive impact for all stakeholders, including its customers.”Over the past year, Accenture’s stock has gained 43.4% while Salesforce and Mastercard stocks have rallied a respective 6.4% and 4.7%. All three stocks carry Zacks Rank #3 (Hold).Accenture PLC Price Accenture PLC price | Accenture PLC QuoteA better-ranked stock in the broader Business Services sector that investors can consider stock is Genpact G, carrying a Zacks Rank #2 (Buy). You can see the complete list of today’s Zacks #1 Rank (Strong Buy) stocks here.The long-term expected earnings per share (three to five years) growth rate for Genpact is pegged at 14.7%. Breakout Biotech Stocks with Triple-Digit Profit Potential The biotech sector is projected to surge beyond $2.4 trillion by 2028 as scientists develop treatments for thousands of diseases. They’re also finding ways to edit the human genome to literally erase our vulnerability to these diseases. Zacks has just released Century of Biology: 7 Biotech Stocks to Buy Right Now to help investors profit from 7 stocks poised for outperformance. Recommendations from previous editions of this report have produced gains of +205%, +258% and +477%. The stocks in this report could perform even better.See these 7 breakthrough stocks now>>Want the latest recommendations from Zacks Investment Research? Today, you can download 7 Best Stocks for the Next 30 Days. Click to get this free report Accenture PLC (ACN): Free Stock Analysis Report Mastercard Incorporated (MA): Free Stock Analysis Report salesforce.com, inc. (CRM): Free Stock Analysis Report Genpact Limited (G): Free Stock Analysis Report To read this article on Zacks.com click here.